AKT-100
AKT-100 is a p53 reactivation agent. AKT-100 significantly inhibits the proliferation of various ovarian and endometrial cancer cells at low concentrations. AKT-100 can upregulate cell cycle regulatory genes (such as p21, GADD45) and pro apoptotic genes (such as NOXA, DR5), and inhibit DNA repair pathways. AKT-100 is commonly used in cancer research[1].
Product Specifications
CAS Number
3076960-67-0
UNSPSC
12352005
Target
MDM-2/p53
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(/C(CN(C(CNC1C(C)(C)N([O])C(C)(C)C1)=O)C/2)=C/C3=CC=C(C#N)C=C3)C2=C\C4=CC=C(C#N)C=C4
Molecular Formula
C31H32N5O3
Molecular Weight
522.62
References & Citations
[1]Williams G L, et al. The novel curcumin analogue AKT-100 targets mutant p53 in gynecologic cancer cells[J]. bioRxiv, 2025: 2025.10. 06.680794.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mucin 5AC (MUC5AC) (45M1), CF405S conjugate, 0.1mg/mL
TYRP1 (Tyrosinase Related Protein 1) (TA99), CF647 conjugate, 0.1mg/mL
CD50 (ICAM-3) (186-2G9), CF594 conjugate, 0.1mg/mL
Mucin 5AC (MUC5AC) (45M1), CF568 conjugate, 0.1mg/mL
Von Willebrand Factor (3E2D10), CF568 conjugate, 0.1mg/mL
